Changes

no edit summary
Line 257: Line 257:  
|Complete
 
|Complete
 
|
 
|
|
+
|Need permission for figure?  Update WHO?
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH
 
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH
Line 275: Line 275:  
|}
 
|}
 
|
 
|
|
+
|Add WHO reference
 
|-
 
|-
 
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg  Conboy (Monash Health)||JH
 
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg  Conboy (Monash Health)||JH
Line 355: Line 355:  
|Complete
 
|Complete
 
|
 
|
|
+
|Need permission for figure?
 
|-
 
|-
 
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley||JH
 
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley||JH